Government of New Brunswick

The NB Drug Plans (New Brunswick Prescription Drug Program and New Brunswick Drug Plan) cover certain smoking cessation therapies for individuals enrolled in Plans ADEFGV.

 

Eligible Benefits


Treatment with either non-nicotine or nicotine replacement therapies will be reimbursed annually without special authorization (SA) as outlined in the tables below:

Option 1: Non-Nicotine Smoking Cessation Therapies*

Product

Strength

DIN (NPN)

Drug Cost

Quantity

Bupropion

Tablet

150mg

See the New Brunswick Drug Plans Formulary for products

MLP

168 tablets

or

Varenicline

Starter Kit 

0.5mg/1mg

See the New Brunswick Drug Plans Formulary for products

MAP

336 tablets

Tablet

0.5 mg

1mg

*18 years of age or older

Option 2: Nicotine Replacement Therapies

Product

Strength

DIN (NPN)

Drug Cost

Quantity

Gum 

2mg

 

See the NB Drug

Plans Formulary for products

MAP

960 pieces

Lozenge

1mg

2mg

3mg

4mg

 

MAP

      

 

960 pieces

Patch

7 mg

14mg

21mg

MAP

168 patches

Only those products for which prices have been confirmed are eligible benefits. 

SA Requests for Additional Quantities

Additional reimbursement of bupropion OR nicotine patches for individuals who have a high probability of quitting with additional therapy will require SA using the Smoking Cessation Therapy Special Authorization Request Form.

Refer to the Smoking Cessation Therapy Special Authorization Request Form for further information on additional quantities of smoking cessation therapies permitted annually.

The Smoking Cessation Therapy Special Authorization Request Form can be completed by a licensed prescriber (physician, nurse practitioner, or pharmacist), nurse, or respiratory therapist. A separate patient prescription must be written by a licensed prescriber for all nicotine replacement and non-nicotine smoking cessation therapies.

 

Pharmacy Claims

 

Pharmacy Audit

  • Claims that do not comply with the policies of the NB Drug Plans are subject to audit and recovery.